TROY, Mich., June 5 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) will release its financial results for the second quarter ended May 31, 2008 before the opening of the market on Wednesday, June 18, 2008. In conjunction with its financial results, the Company will host a conference call that will be webcast live at 10:00 a.m. (ET) the same day.
On the conference call, Bruce Barrett, Somanetics' president and chief executive officer, and Bill Iacona, chief financial officer, will review Somanetics' financial results.
To listen to the webcast, visit the Investor Center page of Somanetics' website at http://www.somanetics.com 15 minutes prior to the event's broadcast and click on the "Second Quarter 2008 Conference Call" link. Interested parties unable to listen to the live call may access the archived version of the call on the Investor Center page of Somanetics' website for one year after the call. Windows Media Player is required for access to the webcast and is available for downloading free of charge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit http://www.somanetics.com .
SOURCE Somanetics Corporation
